Market Intelligence

Access the latest earnings reports, market analysis, hot topics, and individual stock insights

Report Categories

View All

Recent Articles

View All
Is Beta Tech Beta Stock Stabilizing Price At 16.83 Up 1.32 20260413 Is Open Lpro Stock Good For Short Term Price At 1.50 Up 3.45 20260413 How Does Federated Fmn Stock React To Market Crashes Price At 11.03 Up 1.61 20260408 Is Stmicroelectronics N.V. Stm Stock Cheap At Current Price Price At 35.73 Up 4.09 20260406 Is Smj Smjf Stock A Safe Investment Price At 3.30 Down 0.90 20260408 KRUS Kura Sushi posts narrow Q1 2026 EPS beat but shares edge down slightly following earnings release Applied Materials Inc AMAT Terafab Vendor Shortlisting Highlights Unpriced Upside Amid AI Chip Demand Boom How TPG TPG cash generation compares to earnings Q1 2026 EPS Beats Forecasts Moderna Inc MRNA Competitive Vaccine Trial Results and Peer Catalysts Signal NearTerm Commercial Risks CB Chubb Q4 2025 earnings exceed forecasts shares rise on strong revenue growth and solid EPS performance Shattuck Labs STTK Stock High Frequency Skyrockets 20260420 Is Supernus Pharmaceuticals SUPN a value trap or a value play Momentum Fading 20260511 WAT Waters Corporation falls 286 after posting a narrow Q4 2025 EPS miss against analyst expectations HIG The posts 10 percent Q1 2026 EPS miss shares eke out small gain as investors overlook the quarterly shortfall FROG JFrog tops Q4 2025 EPS expectations by 141 percent shares climb 169 percent in todays trading Why Sarepta SRPT earnings always move the needle Q1 2026 EPS Tops Views What Conduent CNDT is doing that smart money tracks Modest Gains 20260508 Why UDR UDR earnings beat or miss matters less than you think Q1 2026 EPS Beats Forecasts Palo Alto Networks Inc PANW Acquisition of Koi Establishes FirstofItsKind Agentic Endpoint Security Category Fed Governor Miran Resigns Endorses Warsh as Next Chair BioNTech BNTX Slides 265 as Selling Pressure Mounts 20260515 Could Orbital Drug Manufacturing Finally Become a Reality The Vanishing Equity Risk Premium What It Means for Investors Jim Cramer Flags Design Therapeutics as Pure Spec What Investors Should Know UK Regulator Grants Conditional Clearance for 37 Billion GettyShutterstock Merger